Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-TT co-administered with Twinrix in healthy adolescents
2006-005999-41Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in meningococcal disease, hepatitis A (HAV) and hepatitis B (HBV) comparing MenACWY-TT + Twinrix, MenACWY-TT alone and Twinrix alone (3 arms). Primary endpoint: rSBA geometric mean titres for meningococcal serogroups A, C, W-135, and Y. Started Dec 2006; status: completed.
02
Drugs
hepatitis b vaccine recombinantmeningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine
03
Conditions
meningococcal diseasehepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2006-005999-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005999-41.